Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quadruple Immunotherapy for Paediatric Patients With Relapsed or Refractory Neuroblastoma

NCT05754684 is registered in ClinicalTrials.gov with Hong Kong Children's Hospital as lead sponsor.

NCT NCT05754684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05754684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quadruple Immunotherapy for Paediatric Patients With Relapsed or Refractory Neuroblastoma
Lead sponsor
Hong Kong Children's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2022
Completion date
December 31, 2025
Enrollment
29 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma recurrent